** Shares of Trajan Group Holdings rise as much as 5% to A$1.260, posting their biggest intraday pct gain since Sept. 10
** Life sciences co says Q1 total net revenue up in high single-digit over pcp
** Maintains FY25 net revenue forecast of A$160.0 mln ($105.31 mln) to A$165.0 mln, and group nEBITDA of A$17.0 mln to A$19.0 mln
** Co had reported net revenue of A$155 mln and group normalised EBITDA of A$17.1 mln for fiscal 2024
** Stock hits highest level since Oct. 7
** TRJ up 2% YTD, as of 0225 GMT
($1 = 1.5193 Australian dollars)
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。